IL6 and COVID-19: The relevance of these anti-inflammatory properties to COVID-19-induced immunopathologies is further highlighted by the accumulating evidence showing association of markedly elevated levels of IL-6 and other pro-inflammatory cytokines in patients with severe COVID-19 clinical outcomes (170).